Kit ELISA SPINT2 sandwich (HAI-2) (human): quantitative determination of Hu SPINT2 in serum, plasma or cell culture medium. The test recognizes only the natural and recombinant forms of Hu SPINT2.
Accession number
O43291
Dose range
3.28-800 pg/ml
Sensitivity of the dosage
3 pg/ml
Calibration range
3 pg/ml to 800 pg/ml
Dose
ELISA solid-phase sandwich
Brand
Invitrogen
Kit ELISA SPINT2 sandwich (HAI-2) (human): quantitative determination of Hu SPINT2 in serum, plasma or cell culture medium. The test recognizes only the natural and recombinant forms of Hu SPINT2.
Kit ELISA SPINT2 sandwich (HAI-2) (human): quantitative determination of Hu SPINT2 in serum, plasma or cell culture medium. The test recognizes only the natural and recombinant forms of Hu SPINT2.
Method principle: This ELISA solid phase sandwich test (immuno-enzymatic dose) measures the amount of target bound between a pair of matched antibodies. A specific target antibody is pre-adsorbed into the wells of the supplied microplate. Samples, standards or controls are added to these wells and bind to immobilized antibodies (capture antibodies). The sandwich is formed by adding the second antibody (detection antibody), then a substrate solution reacts with the enzyme-antibodies-target complex to produce a measurable signal. The intensity of this signal is directly proportional to the concentration of the target present in the original sample.
Rigorous validation: Each batch manufactured from this ELISA kit is checked for criteria such as sensitivity, specificity, accuracy and reproducibility from one batch to another (see the package leaflet for more information on validation).
The HAI-2 is an endogenous inhibitor of Kunitz-type serine proteinase HGF (HGFA) activator. HGF was first described as a hepatocyte-specific mitogen and survival factor. HGF has since been shown to exert a multitude of actions on many types of cells by binding to its MET receptor. The HGF is activated by single chain shape cleavage to produce a two chain version via the HGFA. The enzyme was also inhibited by the enzyme trypsin and MTSP-1 (matriptase-1), a serine proteinase that also activates HGF and HGF-2, the role of which was demonstrated to inhibit the use of Ki nanomolar hepsin. The first name of L-HAI-2 was bikunine, then SPINT2 (serine-2 proteinase inhibitor), a proteinase inhibitor present in amniotic fluid. A protein called a small protein bound to HAI-2 is a protein consisting of 106 amino acids with little homology with HAI-2. However, HAI-2 antibodies do not recognize HAI-2 RSP. HAI-2 antibodies do not recognize HAI-1. Mouse treated with HAI-2 in a model of lovarian cancer had smaller tumours. In addition, HAI-2 would appear to be elevated in macrophages during lovarian cancer, which is considered a favourable indicator of survival. The HAI-2 is secreted and inserted into a membrane via a Type I transmembrane domain. The carboxyterminal end is a cytoplasmic domain that seems to interact with signaling and the cytoskeletal machine. Extracellular domains include two kringle domains (KD1 and KD2). KD2 is considered inactive or with much lower activity against HGF. In mice, dominant HAI-2 lacks the first kringle domain, but the two-domain form dominates in humans, although a shorter HAI-2 was detected in human testicles using a second transcription site.